Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer

INTRODUCTION: Lack of highly expressed tumor target and ligands limits application of nano-medicine against triple-negative breast cancer (TNBC). Previous study reported that placenta-derived oncofetal chondroitin sulfate glycosaminoglycan chain (CSA) expressed on 90% of stage I–III invasive ductal...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chen, Li, Chunbin, Cai, Jiaxuan, Chen, Jie, Wang, Baobei, Li, Mengxia, Zhou, Wei, Wang, Jianguo, Zhang, Pengfei, Zhang, Jian V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700479/
https://www.ncbi.nlm.nih.gov/pubmed/36444194
http://dx.doi.org/10.2147/IJN.S380358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700479/
https://www.ncbi.nlm.nih.gov/pubmed/36444194
http://dx.doi.org/10.2147/IJN.S380358

Ejemplares similares